Jeffrey Scott Riley insider trades

Open-market stock purchases and sales by Jeffrey Scott Riley, Director at Gain Therapeutics, Inc, from SEC Form 4 filings since Dec 2, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • GANX Gain Therapeutics, Inc: 1 buy, last Jun 24, 2025
  • SYN Synthetic Biologics, Inc: 5 buys, last Nov 30, 2016
  • AEN Adeona Pharmaceuticals, Inc: other filings, last Feb 3, 2012

Get free alerts when Jeffrey Scott Riley files a new trade →